Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A biologic is manufactured in a living system such as a microorganism, or plant or animal cells. Most biologics are very large, complex molecules or mixtures of molecules. Many biologics are produced using recombinant DNA technology.
This report elaborates on the current development of the Retinal Drugs and Biologics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Janssen Biotech
Genzyme
Alimera Sciences
UCBCares
Bausch & Lomb
AbbVie
Swedish Orphan Biovitrum
Roche
OCULAR THERAPEUTIX
Genentech
ALLERGAN
Bristol-Myers Squibb
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Application:
Hospitals
Clinics
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Retinal Drugs and Biologics Industry Overview
-
1.1.1 Retinal Drugs and Biologics Market Scope and Market Segments
-
1.1.2 Retinal Drugs and Biologics Industry Characteristics
-
1.1.3 Global and China Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Retinal Drugs and Biologics Production Value and Growth Rate (2017-2028)
-
1.2 Global Retinal Drugs and Biologics Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Age Related Macular Degeneration
-
1.2.2 Diabetic Retinopathy
-
1.2.3 Ocular Inflammatory Disease (Uveitis)
-
1.2.4 Macular Hole
-
1.3 Global Retinal Drugs and Biologics Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospitals
-
1.3.2 Clinics
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Retinal Drugs and Biologics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Retinal Drugs and Biologics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Retinal Drugs and Biologics Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Retinal Drugs and Biologics Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Retinal Drugs and Biologics Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Retinal Drugs and Biologics Industry Porter's Five Forces Model Analysis
-
2.2.3 Retinal Drugs and Biologics Industry PEST Analysis
-
2.3 Retinal Drugs and Biologics Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Retinal Drugs and Biologics Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Retinal Drugs and Biologics Industry
Chapter 3 Global and China Retinal Drugs and Biologics Market, by Manufacturer
-
3.1 Global and China Retinal Drugs and Biologics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Retinal Drugs and Biologics Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Retinal Drugs and Biologics Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Retinal Drugs and Biologics Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Retinal Drugs and Biologics Market Top 3 Players
Chapter 4 Global and China Retinal Drugs and Biologics Market, by Type (2017-2028)
-
4.1 Retinal Drugs and Biologics Market Trend, by Type
-
4.2 Global Retinal Drugs and Biologics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Retinal Drugs and Biologics Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Retinal Drugs and Biologics Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Retinal Drugs and Biologics Price Trend, by Type (2017-2028)
-
4.3 China Retinal Drugs and Biologics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Retinal Drugs and Biologics Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Retinal Drugs and Biologics Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Retinal Drugs and Biologics Price Trend, by Type (2017-2028)
Chapter 5 Global and China Retinal Drugs and Biologics Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Retinal Drugs and Biologics Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Retinal Drugs and Biologics Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Retinal Drugs and Biologics Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Retinal Drugs and Biologics Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Retinal Drugs and Biologics Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Retinal Drugs and Biologics Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Retinal Drugs and Biologics Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Retinal Drugs and Biologics Market Analysis
-
7.1 North America Retinal Drugs and Biologics Market, by Type
-
7.2 North America Retinal Drugs and Biologics Market, by Application
-
7.3 North America Retinal Drugs and Biologics Market Analysis and Forecast, by Country
-
7.3.1 United States Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Retinal Drugs and Biologics Market Analysis
-
8.1 Europe Retinal Drugs and Biologics Market, by Type
-
8.2 Europe Retinal Drugs and Biologics Market, by Application
-
8.3 Europe Retinal Drugs and Biologics Market Analysis and Forecast, by Country
-
8.3.1 Germany Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Retinal Drugs and Biologics Market Analysis
-
9.1 APAC Retinal Drugs and Biologics Market, by Type
-
9.2 APAC Retinal Drugs and Biologics Market, by Application
-
9.3 APAC Retinal Drugs and Biologics Market Analysis and Forecast, by Country
-
9.3.1 China Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Retinal Drugs and Biologics Market Analysis
-
10.1 Latin America, Middle East and Africa Retinal Drugs and Biologics Market, by Type
-
10.2 Latin America, Middle East and Africa Retinal Drugs and Biologics Market, by Application
-
10.3 Latin America, Middle East and Africa Retinal Drugs and Biologics Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Retinal Drugs and Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Retinal Drugs and Biologics Company Profiles
-
11.1 Janssen Biotech
-
11.1.1 Janssen Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Janssen Biotech Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.1.3 Janssen Biotech Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Genzyme
-
11.2.1 Genzyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Genzyme Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.2.3 Genzyme Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Alimera Sciences
-
11.3.1 Alimera Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Alimera Sciences Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.3.3 Alimera Sciences Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 UCBCares
-
11.4.1 UCBCares Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 UCBCares Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.4.3 UCBCares Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Bausch & Lomb
-
11.5.1 Bausch & Lomb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Bausch & Lomb Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.5.3 Bausch & Lomb Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 AbbVie
-
11.6.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 AbbVie Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.6.3 AbbVie Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Swedish Orphan Biovitrum
-
11.7.1 Swedish Orphan Biovitrum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.7.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Roche
-
11.8.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Roche Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.8.3 Roche Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 OCULAR THERAPEUTIX
-
11.9.1 OCULAR THERAPEUTIX Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.9.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Genentech
-
11.10.1 Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Genentech Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.10.3 Genentech Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 ALLERGAN
-
11.11.1 ALLERGAN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 ALLERGAN Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.11.3 ALLERGAN Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Bristol-Myers Squibb
-
11.12.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Bristol-Myers Squibb Retinal Drugs and Biologics Product Profiles, Application and Specification
-
11.12.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Retinal Drugs and Biologics Industry Investment Prospect and Risk Assessment
-
12.1 Retinal Drugs and Biologics Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Retinal Drugs and Biologics Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure China Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Global Retinal Drugs and Biologics Production Value and Growth Rate (2017-2028)
-
Figure China Retinal Drugs and Biologics Production Value and Growth Rate (2017-2028)
-
Figure Global Retinal Drugs and Biologics Market Size and Growth Rate of Age Related Macular Degeneration (2017-2028)
-
Figure Global Retinal Drugs and Biologics Market Size and Growth Rate of Diabetic Retinopathy (2017-2028)
-
Figure Global Retinal Drugs and Biologics Market Size and Growth Rate of Ocular Inflammatory Disease (Uveitis) (2017-2028)
-
Figure Global Retinal Drugs and Biologics Market Size and Growth Rate of Macular Hole (2017-2028)
-
Figure Global Retinal Drugs and Biologics Market Size and Growth Rate of Hospitals (2017-2028)
-
Figure Global Retinal Drugs and Biologics Market Size and Growth Rate of Clinics (2017-2028)
-
Figure Global Retinal Drugs and Biologics Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Retinal Drugs and Biologics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Retinal Drugs and Biologics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Retinal Drugs and Biologics Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Retinal Drugs and Biologics Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Retinal Drugs and Biologics Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Retinal Drugs and Biologics Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Retinal Drugs and Biologics Market Share, by Manufacturer in 2021
-
Figure Global and China Retinal Drugs and Biologics Market Share, by Manufacturer in 2022
-
Table Global Retinal Drugs and Biologics Sales Volume, by Type (2017-2028)
-
Table Global Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Figure Global Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Table Global Retinal Drugs and Biologics Sales Value, by Type (2017-2028)
-
Table Global Retinal Drugs and Biologics Sales Value Share, by Type (2017-2028)
-
Figure Global Retinal Drugs and Biologics Price Trend, by Type (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Volume, by Type (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Figure China Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Value, by Type (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Value Share, by Type (2017-2028)
-
Figure China Retinal Drugs and Biologics Price Trend, by Type (2017-2028)
-
Table Global Retinal Drugs and Biologics Sales Volume, by Application (2017-2028)
-
Table Global Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure Global Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Table Global Retinal Drugs and Biologics Sales Value, by Application (2017-2028)
-
Table Global Retinal Drugs and Biologics Sales Value Share, by Application (2017-2028)
-
Figure Global Retinal Drugs and Biologics Sales Value Share, by Application (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Volume, by Application (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure China Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Value, by Application (2017-2028)
-
Table China Retinal Drugs and Biologics Sales Value Share, by Application (2017-2028)
-
Figure China Retinal Drugs and Biologics Sales Value Share, by Application (2017-2028)
-
Figure China Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
Figure North America Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Retinal Drugs and Biologics Production, Import, Consumption and Export (2017-2022)
-
Table North America Retinal Drugs and Biologics Sales Volume, by Type (2017-2028)
-
Table North America Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Figure North America Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Table North America Retinal Drugs and Biologics Sales Volume, by Application (2017-2028)
-
Table North America Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure North America Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure United States Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure United States Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Canada Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Table Europe Retinal Drugs and Biologics Sales Volume, by Type (2017-2028)
-
Table Europe Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Figure Europe Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Table Europe Retinal Drugs and Biologics Sales Volume, by Application (2017-2028)
-
Table Europe Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure Europe Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure Germany Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure UK Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure UK Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure France Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure France Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Italy Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Spain Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Poland Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Russia Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Table APAC Retinal Drugs and Biologics Sales Volume, by Type (2017-2028)
-
Table APAC Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Figure APAC Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Table APAC Retinal Drugs and Biologics Sales Volume, by Application (2017-2028)
-
Table APAC Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure APAC Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure China Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure China Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Japan Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure India Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure India Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Retinal Drugs and Biologics Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Retinal Drugs and Biologics Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Retinal Drugs and Biologics Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Retinal Drugs and Biologics Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Retinal Drugs and Biologics Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Retinal Drugs and Biologics Sales Value and Growth Rate (2017-2028)
-
Table Janssen Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Janssen Biotech Product Profiles, Application and Specification
-
Table Janssen Biotech Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genzyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genzyme Product Profiles, Application and Specification
-
Table Genzyme Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alimera Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alimera Sciences Product Profiles, Application and Specification
-
Table Alimera Sciences Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table UCBCares Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table UCBCares Product Profiles, Application and Specification
-
Table UCBCares Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bausch & Lomb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bausch & Lomb Product Profiles, Application and Specification
-
Table Bausch & Lomb Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Swedish Orphan Biovitrum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Swedish Orphan Biovitrum Product Profiles, Application and Specification
-
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table OCULAR THERAPEUTIX Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table OCULAR THERAPEUTIX Product Profiles, Application and Specification
-
Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genentech Product Profiles, Application and Specification
-
Table Genentech Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table ALLERGAN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ALLERGAN Product Profiles, Application and Specification
-
Table ALLERGAN Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Retinal Drugs and Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
